THE NICKLES GROUP, LLC - 2025 third_quarter

Health Issues

Monitored issues related to medical supply chain and pharmacy benefit management. Monitored issues related to drug pricing. Issue regarding plasma-based therapies.

HOUSE OF REPRESENTATIVESSENATE

Taxation/Internal Revenue Code

View all

H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to foreign-based corporations, and corporate taxes.

HOUSE OF REPRESENTATIVESSENATE

Trade (domestic/foreign)

View all

Issues related to tariffs.

Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESSENATE

Medicare/Medicaid

View all

Issues related to plasma based therapies.
H.R. 1476 / S. 694, Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act. Issues related to gene therapies. Issues related to value-based payments. Issues related to drug shortages. Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to plasma derived products and drug pricing.
H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act. Issues related to pharmacy benefit management. Issues related to Most Favored Nation drug pricing.

Centers For Medicare and Medicaid Services (CMS)Executive Office of the President (EOP)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATE

2025 third_quarter Filing

Lobbying Activities (4)

Health Issues

Taxation/Internal Revenue Code

Trade (domestic/foreign)

Medicare/Medicaid

Lobbyists (4)